Our partnerships
Cancer Research Horizons partners across the fields of academia, industry, drug discovery and investors.
Data partnerships
We maximise the potential of our cancer data through improved access, usage, and secure, patient-approved partnerships.
Enhancing data accessibility
Our research network generates a substantial volume of cancer data that can drive innovation and improve patient outcomes. To unlock the potential of this data, we're working to enhance how both researchers and commercial partners can access and use it.
Our data assets
Licensing and collaboration
We have a number of oncology-focused data projects available for licensing or collaboration as well as some pending opportunities that we are keen to explore further with partners.
Our guiding principles
To maximise the potential of the data our research network generates, we facilitate secure, patient-approved data partnerships established in a safe, secure and transparent manner.
To govern these relationships, in consultation with industry and patients and the public we have developed a set of guiding principles and a comprehensive patient involvement process.
Data Innovation Awards
Access funding
Our Data Innovation Awards provide researchers with up to £100,000 funding to be used to support cleaning, annotation, curation, linking or storage of data that has significant commercial potential. We also provide support and guidance to navigate the complexity of sharing patient-derived data and ensure any partnerships are safe, secure and performed in consultation with patients.
OPTIMAM
Case study
Artificial intelligence is set to revolutionise many aspects of cancer diagnosis and treatment – but AI is only as good as the data used to train it. Discover how we are supporting the development AI tools in breast cancer detection through enabling access to the OPTIMAM dataset.
Find out more about partnering with us
We're seeking powerful partnerships with research institutions, commercial organisations, researchers and investors.